US · Healthcare · Biotechnology
EPS came in at -2.44 against a street estimate of -2.71 — a beat of 10.0%.
Analysts rate Tonix Pharmaceuticals Holding Corp a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $44.50.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.15% |
| Point72 Asset Management, L.P. | 6.80% |
| Millennium Management LLC | 5.64% |
| AQR Capital Management LLC | 5.15% |
| Vanguard Capital Management, LLC | 4.03% |
| Jones Hill Capital LP | 3.65% |
| Geode Capital Management, LLC | 2.30% |
| Ishara Investments LP | 1.97% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tonix Pharmaceuticals Holding Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.